Epcoritamab has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for B-cell Lymphomas in the third- or later-line setting for the treatment of patients with diffuse large B-cell lymphoma.
Guidelines | Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Articles
Videos
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Advertisement
Advertisement
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
Mortality Gap Between Puerto Rico and the US Mainland Among Medicare Advantage Enrollees
5
